Author(s): Hamadah I, Binamer Y, Sanai FM, Abdo AA, Alajlan A, Hamadah I, Binamer Y, Sanai FM, Abdo AA, Alajlan A
Abstract Share this page
Abstract BACKGROUND: Vitiligo is an autoimmune disease characterized by depigmented patches and macules. It is associated with many autoimmune diseases, the most common of which is thyroid disease. The association between Interferon (IFN) therapy and vitiligo is rarely reported in the literature, despite its common usage in hepatitis B viral infection, hepatitis C viral infection (HCV), hematological malignancies and melanoma. CASE: We are reporting eight cases of vitiligo that appeared after treating HCV with IFN. CONCLUSION: Interferon unmasks vitiligo in susceptible individuals.
This article was published in Int J Dermatol
and referenced in Journal of Liver